Cryoglobulinemia in a moroccan nephrology department.
Cryoglobulinemia in a moroccan nephrology department. Saudi J Kidney Dis Transpl. 2019 May-Jun;30(3):663-669 Authors: Azizi M, Rafik H, Zajjari Y, Montasser DI, El Kabbaj D Abstract Cryoglobulinemia is a rare cause of kidney disease that occurs in patients with various diseases. Renal involvement often occurs after appearance of various clinical manifestations dominated by purpura and neuropathy. The aim of this study is to describe clinical, biological, and pathological characteristics of cryoglobulinemic glomerulonephritis (GN), as well as treatment and outcome. This is a retrospective study including all patients with positive cryoglobulin test and biopsy-proven GN secondary to cryoglobulinemia. Fourteen patients with cryoglobulinemic GN were collected. Their mean age was 46.92 ± 15.82 years with male predominance (64.28%). Weight loss, fever (71.42%), and purpuric rash (57.14%) were the main extrarenal manifestations. Eight patients presented with nephrotic syndrome (NS), associated with renal impairment in three patients. Four patients had rapidly progressive GN and two patients had acute kidney injury. Renal biopsy, performed in all patients, revealed membranoproliferative GN with glomerular thrombi in all patients. Crescents and necrotizing vasculitis were present in four patients. Hepatitis C virus (HCV) infection was the most common etiology. Antivirals and steroids or other immunosuppressive agents were used in most of the patients. Duri...
CONCLUSIONS: Glecaprevir/pibrentasvir was effective and well tolerated in treatment-naïve Brazilian patients with hepatitis C infection without cirrhosis and with compensated cirrhosis. TRIAL REGISTRATION: ClinicalTrials.gov NCT03219216. PMID: 32949786 [PubMed - as supplied by publisher]
Publication date: Available online 20 September 2020Source: Journal of Saudi Chemical SocietyAuthor(s): Zhen-Wei Tian, Xiao-Qian Cui, Jia-Kun Tian, Mu-Chen Cui, Li Jin, Ran Jia, Roberts I. Eglitis
Publication date: Available online 20 September 2020Source: Journal of Saudi Chemical SocietyAuthor(s): Ya-Gai Wang, Jing Li, Xiao-Die Wang, Linlin Shi, Xinju Zhu, Xin-Qi Hao, Mao-Ping Song
Publication date: October 2020Source: American Journal of Kidney Diseases, Volume 76, Issue 4Author(s): Sarthak Virmani, William S. Asch
Publication date: Available online 21 September 2020Source: American Journal of Kidney DiseasesAuthor(s): Ronald L. Pisoni, Lindsay Zepel, Junhui Zhao, Steven Burke, Charmaine E. Lok, Kenneth J. Woodside, Haimanot Wasse, Hideki Kawanishi, Douglas Schaubel, Jarcy Zee, Bruce M. Robinson
BACKGROUND: Falls experienced by patients undergoing blood and marrow transplantation or treatment with cellular immunotherapy (BMT-CI) may result in injury or death. An algorithm was developed using the patient fall circumstances identified in a chart ana...
This study aims at revealing th...
Condition: Renal Disease Intervention: Drug: Sugammadex Sponsor: Tetsuro Sakai Not yet recruiting
Conditions: Leukemia; Lymphoma; Lymphoma, B-Cell Intervention: Biological: CAR T-Cell Infusion Sponsor: Memorial Sloan Kettering Cancer Center Recruiting
Condition: Intrahepatic Cholangiocarcinoma Intervention: Procedure: Liver Transplant Sponsor: Oslo University Hospital Recruiting